Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker?
作者信息
Comentale Giuseppe, Manzo Rachele, Pilato Emanuele
机构信息
Division of Advanced Biomedical Sciences, University of Napoli "Federico II", Naples, Italy.
出版信息
J Mol Med (Berl). 2020 Aug;98(8):1053-1054. doi: 10.1007/s00109-020-01945-4. Epub 2020 Jun 29.
Abstract
摘要
相似文献
1
Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker?严重急性呼吸综合征冠状病毒2（Sars-Cov-2）对血红素生成的干扰：现在是时候寻找早期预测生物标志物了吗？
J Mol Med (Berl). 2020 Aug;98(8):1053-1054. doi: 10.1007/s00109-020-01945-4. Epub 2020 Jun 29.
2
COVID-19, Renin-Angiotensin System, and Hematopoiesis.新型冠状病毒肺炎、肾素-血管紧张素系统与造血作用
Turk J Haematol. 2020 Aug 28;37(3):207-208. doi: 10.4274/tjh.galenos.2020.2020.0174. Epub 2020 May 12.
3
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
4
COVID-19 challenging cell biology.新冠病毒对细胞生物学构成挑战。
Protoplasma. 2020 May;257(3):619-620. doi: 10.1007/s00709-020-01506-z. Epub 2020 Apr 24.
5
The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2 或 n-COVID-19）的蛋白，引发 COVID-19。
Protein J. 2020 Jun;39(3):198-216. doi: 10.1007/s10930-020-09901-4.
6
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention.SARS-CoV-2 进入宿主细胞的途径——治疗和预防的多个靶点。
Biochimie. 2020 Aug;175:93-98. doi: 10.1016/j.biochi.2020.05.012. Epub 2020 May 29.
7
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.SARS-CoV-2 的 nsp13、nsp14、nsp15 和 orf6 具有很强的干扰素拮抗作用。
Emerg Microbes Infect. 2020 Dec;9(1):1418-1428. doi: 10.1080/22221751.2020.1780953.
8
Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?人类唾液蛋白质组与2019冠状病毒病（COVID-19）大流行：一种被低估的关联？
Front Immunol. 2020 Jun 23;11:1480. doi: 10.3389/fimmu.2020.01480. eCollection 2020.
9
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?肾素-血管紧张素系统与新型冠状病毒2019感染：血管紧张素转换酶2受体的作用？
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926911. doi: 10.1177/1470320320926911.
10
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?COVID-19：我们是否正在应对一种伪装成病毒感染的多系统血管病？
J Thromb Thrombolysis. 2020 Oct;50(3):567-579. doi: 10.1007/s11239-020-02210-8.
引用本文的文献
1
Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023.2023年新冠病毒感染患者红细胞的形态与功能：当前概述
Life (Basel). 2024 Apr 1;14(4):460. doi: 10.3390/life14040460.
2
Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak.纳米科学在2019冠状病毒病中的卓越潜力与未来前景：针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）爆发进行有效诊断与管理的重要方法
Chem Zvesti. 2023 Apr 4:1-24. doi: 10.1007/s11696-023-02795-3.
3
Spectral and theoretical study of SARS-CoV-2 ORF10 protein interaction with endogenous and exogenous macroheterocyclic compounds.SARS-CoV-2 ORF10 蛋白与内源性和外源性大杂环化合物相互作用的光谱和理论研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Oct 15;279:121403. doi: 10.1016/j.saa.2022.121403. Epub 2022 May 17.
4
COVID-19 and erythrocrine function: The roller coaster and danger.COVID-19 与红细胞功能：过山车与危险。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221103151. doi: 10.1177/03946320221103151.
5
Rural and Female Patients with Old Myocardial Infarction Lacked Knowledge and Preventive Measures During the Beginning of the COVID-19 Epidemic in Chongqing, Southwest China.在中国西南部重庆市新冠疫情初期，农村地区及女性老年心肌梗死患者缺乏相关知识及预防措施。
Med Sci Monit. 2021 Sep 13;27:e928512. doi: 10.12659/MSM.928512.
6
An update to "novel therapeutic approaches for treatment of COVID-19".《新型冠状病毒肺炎治疗的新型治疗方法》更新版
J Mol Med (Berl). 2021 Feb;99(2):303-310. doi: 10.1007/s00109-020-02027-1. Epub 2021 Jan 3.
7
Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities.通过定量 RT-PCR 诊断新型 SARS-CoV-2：变异与机遇。
J Mol Med (Berl). 2020 Dec;98(12):1727-1736. doi: 10.1007/s00109-020-01992-x. Epub 2020 Oct 17.
8
Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis.右旋美沙芬和氟哌啶醇对 SARS-CoV-2 NSP6 偏向性活性的研究：计算机模拟结合机制分析。
J Mol Med (Berl). 2020 Dec;98(12):1659-1673. doi: 10.1007/s00109-020-01980-1. Epub 2020 Sep 23.
本文引用的文献
1
Precision Medicine in COVID-19: IL-1β a Potential Target.COVID-19中的精准医学：白细胞介素-1β作为一个潜在靶点
JACC Basic Transl Sci. 2020 Apr 18;5(5):543-544. doi: 10.1016/j.jacbts.2020.04.006. eCollection 2020 May.
2
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.新型冠状病毒肺炎与血栓栓塞性疾病：预防、抗栓治疗与随访的相关问题：美国心脏病学会临床实践更新。
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973. doi: 10.1016/j.jacc.2020.04.031. Epub 2020 Apr 17.
3
Venous thromboembolism in COVID-19 patients.新冠肺炎患者的静脉血栓栓塞症
J Thromb Haemost. 2020 Jun;18(6):1516-1517. doi: 10.1111/jth.14842.
4
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
5
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.与 2019 年冠状病毒病（COVID-19）严重疾病和死亡相关的血液学、生物化学和免疫生物标志物异常：荟萃分析。
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.
6
Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?补体抑制会成为治疗新冠病毒相关全身性血栓形成的新靶点吗？
Circulation. 2020 Jun 2;141(22):1739-1741. doi: 10.1161/CIRCULATIONAHA.120.047419. Epub 2020 Apr 9.
7
The versatile heparin in COVID-19.新冠疫情中用途广泛的肝素。
J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.
8
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.严重 COVID-19 中的细胞因子释放综合征：白细胞介素-6 受体拮抗剂托珠单抗可能是降低死亡率的关键。
Int J Antimicrob Agents. 2020 May;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954. Epub 2020 Mar 29.
9
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).早期抗病毒治疗有助于减轻新型冠状病毒病 (COVID-19) 患者的病情严重程度并改善预后。
J Intern Med. 2020 Jul;288(1):128-138. doi: 10.1111/joim.13063. Epub 2020 Apr 20.
10
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病（COVID-19）在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制：范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.
Zotero 插件